Atlas market file · Equity · United States
Acadia Healthcare Company, Inc.ACHC
- Last close
- 30.72
- Change
- -4.71%
- 96-bar range
- 21.6 – 35.83
- As of
- 6 Aug 2026
Acadia Healthcare Company, Inc. is a services-specialty outpatient facilities, nec issuer listed as ACHC on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-61.56% over the window).
Source rail: Yahoo Finance chart API (ACHC). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ACHC. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
ACHC public profile
Services-specialty outpatient facilities, nec issuer. Acadia Healthcare Company, Inc. is connected to current market context, cited company sources and its retained research file.
Acadia Healthcare Company, Inc. trades as ACHC on NASDAQ. Acadia Healthcare Company, Inc. (ACHC) has a latest verified close of 30.72, down 4.71%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ACHC under USA Stocks and Healthcare & Medicine Stocks for browsing.
What changed for Acadia Healthcare Company, Inc. today
Acadia Healthcare’s first-quarter 2026 filing lands with the quiet thud of a pager left on a hospital tray. Revenue clocked $828.8 million, but net income was a meagre $4.1 million, while cash from operations, at $61.5 million, barely covered the $76.6 million spent on property, plant, and equipment. The glossy product pages-Connections outpatient networks, Children’s Behavioral Solutions, and Military Support programmes-describe programmes that sound impressive until you realise $11.7 million of the revenue was actually earned in 2025 and booked in 2026, a lag so long it reads like a claims backlog unwind. (source: ACHC SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1520697/000119312526192508/achc-20260331.htm)
What Acadia actually does is operate behavioural healthcare facilities across the United States and Puerto Rico, marketing programmes for outpatient wellness, children’s behavioural health, and military support. The company’s website showcases smiling faces, therapy dogs, and reassuring blue skies, but the balance sheet shows $5.55 billion in assets against $3.38 billion in liabilities, with only $158.5 million in cash and equivalents. The glossy front end meets the hard back end: a company that is still unwinding last year’s revenue while funding this year’s buildings. (source: ACHC SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1520697/000119312526192508/achc-20260331.htm)
The filings themselves are a study in contrasts. The 10-Q confirms that services are bundled into single performance obligations satisfied over time, so revenue recognition lags care delivery. The company’s inventory is a modest $5.9 million, while its weighted average diluted share count stands at 90.9 million shares, up from 90.4 million in the prior period. Dilution, not buybacks, is the visible hand on the register, with the board’s recent 13G filings and an S-8 registration showing insiders and executives preparing for more shares rather than fewer. The optics gap between ‘premier provider’ and ‘diluting equity’ is so wide it could double as a waiting room. (source: ACHC SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1520697/000119312526192508/achc-20260331.htm)
The company’s product pages-Connections outpatient networks, Children’s Behavioral Solutions, and Military Support-are real offerings, but they don’t change the cash math. Acadia’s $1.96 billion in equity is underpinned by $3.38 billion in liabilities, leaving a leverage profile that would make a concentrated-loan banker wince. The operating cash flow of $61.5 million is positive but insufficient to cover the $76.6 million in capex, and with only $158.5 million in cash, the question is not growth but survival. The board’s recent 13G filings and S-8 registration point to dilution, not buybacks, a gap between the polished story and the plain ledger. (source: ACHC SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1520697/000119312526192508/achc-20260331.htm)
For a deeper look at Acadia’s programmes and services, see the company’s official pages on outpatient networks, children’s behavioural solutions, and military support, all of which describe real offerings but do not alter the cash and leverage arithmetic. (source: Outpatient & Wellness Services | Acadia Healthcare, https://www.acadiahealthcare.com/programming-treatment/connections/; Children’s Behavioral Solutions Services | Acadia Healthcare, https://www.acadiahealthcare.com/programs-and-services/childrens-behavioral-solutions/; Specialized Treatment for Military | Acadia Healthcare, https://www.acadiahealthcare.com/programs-and-services/military-support)
Acadia has also flagged a data security incident involving certain patient information, a reminder that operational risks extend beyond the balance sheet into the realm of cyber and compliance. (source: Children’s Behavioral Solutions Services | Acadia Healthcare, https://www.acadiahealthcare.com/programs-and-services/childrens-behavioral-solutions/)
If you’re chasing the stock, the filing trail is what matters: revenue, profit, cash flow, capex, dilution, and the pace at which the company unwinds its backlog. The rest is brochure copy. (source: ACHC SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1520697/000119312526192508/achc-20260331.htm)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ACHC technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ACHC
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ACHC research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ACHC FAQ
What is Acadia Healthcare Company, Inc. (ACHC)?Acadia Healthcare Company, Inc. (ACHC) has a latest verified close of 30.72, down 4.71%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Acadia Healthcare Company, Inc. (ACHC) has a latest verified close of 30.72, down 4.71%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ACHC?Acadia Healthcare Company, Inc. (ACHC) has a latest verified close of 30.72, down 4.71%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
Acadia Healthcare Company, Inc. (ACHC) has a latest verified close of 30.72, down 4.71%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ACHC under USA Stocks and Healthcare & Medicine Stocks for browsing.
How often is the ACHC page updated?The ACHC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The ACHC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ACHC?The ACHC file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:ACHC. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The ACHC file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:ACHC. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ACHC?Yes. The workstation can open ACHC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ACHC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ACHC page investment advice?No. The ACHC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The ACHC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
ACHC
Equity · evidence first